Novo Still Has Work to Do to Build Investor Confidence, CEO Says
Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. "We should also have a mindset that we don't have a patent or a monopoly on all the good ideas," Doustdar tells Bloomberg Television. "When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps." (Source: Bloomberg)
READ NEXT
More on the wire
FROM THE PUBLISHER
In 2021, as a whistleblower emerged with dramatic allegations that Facebook was harming children, CEO Mark Zuckerberg posted a rebuttal on Facebook. “We care deeply about issues like safety, well-being and mental health. It’s difficult to see coverage that misrepresents our work and our motives,” he wrote in a note to Meta staff, which he […]
FROM THE PUBLISHER
Energy groups are putting pressure on Gov. Kathy Hochul to refire the Indian Point nuclear plant during green “climate week” events this week.
FROM THE PUBLISHER
"I'm not political, and neither is Saritha. When I met her, I heard somebody who wants change. Saritha is the only person I'll vote for," the grieving mom says in her endorsement of Saritha Komatireddy.